<DOC>
	<DOCNO>NCT03079115</DOCNO>
	<brief_summary>The purpose test whether short-term , high-dose atorvastatin treatment ( 80mg daily ( QD ) 3 day 3 day CAS , 20 mg QD 30 day CAS ) superior conventional-dose atorvastatin treatment ( 20 mg QD 3 day 30 day CAS ) , term efficacy prevention periprocedural ischemic brain damage Chinese patient undergo CAS .</brief_summary>
	<brief_title>High Dose Atorvastatin Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting</brief_title>
	<detailed_description>Chinese patient carotid stenosis schedule selective CAS randomize two group . The High-dose Atorvastatin group receive Atorvastatin 80 mg QD 3 day 3 day CAS , 20 mg QD 30 day CAS , Conventional-dose Atorvastatin group receive Atorvastatin 20 mg QD 3 day 30 day CAS . All patient receive cerebral diffusion-weighted ( DW ) -MRI within 24-72 hr CAS . Then , also receive repeat DW-MRI within 24-72 hr CAS . Efficacy prevention periprocedural ischemic brain damage two different Atorvastatin treatment compare , term periprocedural incidence transient ischemic attack ( TIA ) / ischaemic stroke new ischemic lesion cerebral DW-MRI .</detailed_description>
	<mesh_term>Carotid Stenosis</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>≥ 50 % stenosis internal carotid artery symptomatic patient ; ≥ 70 % stenosis internal carotid artery asymptomatic patient receive statin therapy ≥ 2weeks inclusion nonatherosclerotic carotid disease ( dissection , radiationinduced stenosis ) receive endovascular procedure within 30 day inclusion CAS procedure urgent endovascular therapy acute ischaemic stroke need oral anticoagulant therapy high risk bleed contraindication antiplatelet therapy ( eg : platelet count &lt; 70 X 109/L ) active hepatic disease hepatic dysfunction , aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &gt; 1.5 upper normal limit myopathy increase creatine kinase ( CK ) &gt; 2 upper normal limit renal failure serum creatinine ( Scr ) &gt; 3 mg/dl 264μmol/L unable undergo MRI claustrophobia pacemaker pregnancy , lactation , child bear potential woman without effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Atorvastatin</keyword>
</DOC>